主管单位:中华人民共和国
国家卫生健康委员会
主办单位:中国医师协会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Gan Shiying Jiao Zuoyi
单位:兰州大学第二医院普通外科,兰州730030 甘世英为兰州大学第二医院普通外科在读专业型硕士研究生
英文单位:Department of General Surgery the Second Hospital Lanzhou University Lanzhou 730030 China Gan Shiying is a professional master candidate in the Department of General Surgery of the Second Hospital Lanzhou University
英文关键词:Gastricsignetringcellcarcinoma;Molecularcharacteristics;Chemotherapyresistance;Prognosis
近年来胃癌发病率有所下降,但胃印戒细胞癌发病率显著升高。相较于非印戒细胞癌,晚期胃印戒细胞癌的预后较差,这与其分子病理学特征及化疗耐药密切相关。胃印戒细胞癌的分子表达谱有望成为潜在的治疗靶点及生物标志物。现本文就胃印戒细胞癌的分子病理学特征及其治疗的最新进展进行综述。
Recent years, the incidence of gastric cancer has decreased but the rate of gastric signet ring cell carcinoma(GSRCC) has distinctly increased by year. Compared with non-GSRCC, the prognosis of patient with GSRCC is extremely poor, which is closely related to its special pathological and molecular features and poor sensibility of chemotherapy drugs. Moreover, some molecular expressions may be potential therapeutic targets and biomarkers. Now we have reviewed the progress of GSRCC.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。